Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 6 hours agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Analysis | Biden wants hospitals to report data on gunshot wounds
Washington Post· 4 hours agoToday’s edition: Doctors are urging the federal government to probe whether the coronavirus can...
TASC sees more demand for alcohol treatment - The Republic News
The Republic News· 5 days agoColumbus Regional Health’s Treatment and Support Center, or TASC, is on pace to see a record number of people seek help with alcohol abuse. As of Wednesday, TASC had seen 255 patients struggling ...
Four years after the pandemic, this Fresno business is still feeling the shutdown
Fresno Bee via Yahoo News· 4 days agoFour years ago, the world shut down. Or at least, that’s how it felt, especially to the owners of...
The Strange Villainization of the Walkable City
The New Republic via Yahoo News· 6 days agoThen came the Covid-19 pandemic, which brought a flood of high-profile attention to the 15-minute city. A group of nearly 100 mayors committed to...
Desperate hunger in Tigray pushes thousands into the hands of kidnappers and people smugglers
The Telegraph via Yahoo News· 3 days agoIf he had finished his education, Aregawy Tekle Birham, 23, believes he never would have left...
Seventy-seventh World Health Assembly – Daily update: 30 May 2024
World Health Organization· 7 days agoTransplantation is a life-saving treatment. The latest data of 2022 from the Global Observatory on...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoVisiongain has published a new report: Genome Editing Technologies Market Report 2024-2034: Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application (Genetic Engineering (Cell Line Engineering, Animal Genetic Engineering
First Patient Gets mRNA Bowel Cancer Vaccine In England, With Thousands More Coming
IFLScience· 6 days agoThere’s great news today for cancer patients in England, as thousands are set to be fast-tracked...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 4 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.